Albireo Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Albireo Pharma has a total shareholder equity of $100.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $321.2M and $221.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$222.48m |
Equity | US$100.07m |
Total liabilities | US$221.15m |
Total assets | US$321.22m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ALBO *'s short term assets ($238.8M) exceed its short term liabilities ($37.8M).
Long Term Liabilities: ALBO *'s short term assets ($238.8M) exceed its long term liabilities ($183.3M).
Debt to Equity History and Analysis
Debt Level: ALBO * is debt free.
Reducing Debt: ALBO * has no debt compared to 5 years ago when its debt to equity ratio was 2.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALBO * has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ALBO * has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 35.9% each year.